Top

Neurology and Therapy

Published in:

Open Access 14-09-2023 | Diroximel Fumarate | LETTER

Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”

Authors: Brittney Lager, Jacob Liseno, Ivan Božin, Sarah M. England, Sai L. Shankar, Jason P. Mendoza, James B. Lewin

Published in: Neurology and Therapy | Issue 6/2023

Excerpt

Dear Editor, …

Naismith RT, Wundes A, Ziemssen T, et al. Diroximel fumarate demonstrates an improved gastrointestinal tolerability profile compared with dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: results from the randomized, doubleblind, phase III EVOLVE-MS-2 study. CNS Drugs. 2020;34(2):185–96. https://doi.org/10.1007/s40263-020-00700-0.CrossRefPubMedPubMedCentral

Naismith RT, Wolinsky JS, Wundes A, et al. Diroximel fumarate (DRF) in patients with relapsingremitting multiple sclerosis: interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Mult Scler. 2020;26(13):1729–39. https://doi.org/10.1177/1352458519881761.CrossRefPubMed

Araujo L, Geertsen SS, Amedume A, et al. Persistence, adherence, and switching to higher-cost therapy in patients with multiple sclerosis initiating oral disease- modifying therapies: a retrospective real-world study. Neurol Ther. 2022;11(4):1735–48. https://doi.org/10.1007/s40120-022-00404-1.CrossRefPubMedPubMedCentral

Title: Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
Authors: Brittney Lager
Jacob Liseno
Ivan Božin
Sarah M. England
Sai L. Shankar
Jason P. Mendoza
James B. Lewin
Publication date: 14-09-2023
Publisher: Springer Healthcare
Keywords: Diroximel Fumarate
Dimethyl Fumarate
Multiple Sclerosis
Published in: Neurology and Therapy / Issue 6/2023
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI: https://doi.org/10.1007/s40120-023-00536-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2023

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit

Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Effect of PLA2G6 and SMPD1 Variants on the Lipid Metabolism in the Cerebrospinal Fluid of Patients with Parkinson's Disease: A Non-targeted Lipidomics Study

Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells

Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment

Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial